Stock Events

Medtronic 

$81.04
3440
-$0.62-0.76% Friday 20:00

Statistics

Day High
81.54
Day Low
80.52
52W High
88.75
52W Low
67.71
Volume
3,678,571
Avg. Volume
7,138,221
Mkt Cap
107.61B
P/E Ratio
25.73
Dividend Yield
3.46%
Dividend
2.8

Upcoming

Dividends

3.46%Dividend Yield
10Y Growth
8.85%
5Y Growth
5.65%
3Y Growth
4.14%
1Y Growth
1.45%

Earnings

23MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
1.11
1.26
1.42
1.57
Expected EPS
1.45
Actual EPS
1.46

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MDT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap187.15B
Abbott Laboratories competes directly with Medtronic in the medical device sector, particularly in cardiovascular and diabetes care products.
Boston Scientific
BSX
Mkt Cap113.37B
Boston Scientific Corporation is a major competitor in the medical devices market, especially in areas like cardiac and vascular products, competing directly with Medtronic's offerings.
Johnson & Johnson
JNJ
Mkt Cap353.97B
Johnson & Johnson, through its medical devices division, competes across several areas including surgical products and orthopaedics, overlapping with Medtronic's product lines.
Smith & Nephew
SNN
Mkt Cap11.52B
Smith & Nephew competes with Medtronic in the orthopedics segment, offering similar products for joint replacement and advanced wound management.
Stryker
SYK
Mkt Cap133.08B
Stryker Corporation is a competitor in the medical technology field, particularly in orthopaedics, neurotechnology, and spine products, which competes with Medtronic's offerings.
Zimmer Biomet
ZBH
Mkt Cap23.32B
Zimmer Biomet Holdings, Inc. competes in the orthopedic product space, offering similar products to Medtronic, particularly in the areas of spine and joint reconstruction.
Edwards Lifesciences
EW
Mkt Cap53.11B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, competing with Medtronic's cardiovascular group.
Baxter International
BAX
Mkt Cap16.9B
Baxter International Inc. competes with Medtronic in the medical devices and hospital products sector, particularly in areas like renal care and advanced surgery.
Intuitive Surgical
ISRG
Mkt Cap148.13B
Intuitive Surgical, Inc. competes in the medical devices sector with its robotic surgical systems, a growing area that poses competition to Medtronic's surgical products.
Hologic
HOLX
Mkt Cap17.39B
Hologic, Inc. competes with Medtronic in the medical imaging and diagnostics field, particularly in women's health, an area where Medtronic also operates.

Analyst Ratings

90.57$Average Price Target
The highest estimate is $105.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
25%
Hold
50%
Sell
25%

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Show more...
CEO
Employees
95000
Country
IE
ISIN
IE00BTN1Y115
WKN
000A14M2J

Listings